CORESTEMCHEMON Inc. — Investor Relations & Filings
CORESTEMCHEMON Inc. is a biotechnology company operating through two main divisions: a biopharmaceutical unit and a non-clinical Contract Research Organization (CRO) unit. The biopharmaceutical division is dedicated to the research and development of new drugs based on stem cell therapy technology. Its clinical pipeline primarily targets neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), cerebellar ataxia, and multiple sclerosis, as well as autoimmune diseases like systemic lupus erythematosus (SLE) and fibrosis. The non-clinical CRO division provides comprehensive preclinical services, conducting essential toxicity and efficacy evaluations for pharmaceuticals, biopharmaceuticals, cosmetics, and medical devices to support regulatory approval processes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 주요사항보고서(자기주식처분결정) | 2025-12-23 | Korean | |
| 증권발행결과(자율공시) (유상증자(주주배정후 실권주 일반공모)) | 2025-11-11 | Korean | |
| 증권발행실적보고서 | 2025-11-11 | Korean | |
| 유상증자또는주식관련사채등의청약결과(자율공시) (주주배정후 실권주 일반공모) | 2025-11-10 | Korean | |
| 유상증자또는주식관련사채등의청약결과(자율공시) (주주배정후 실권주 일반공모) | 2025-11-05 | Korean | |
| 유상증자최종발행가액확정 (주주배정후 실권주 일반공모) | 2025-10-30 | Korean |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 12201747 | 주요사항보고서(자기주식처분결정) | 2025-12-23 | Korean | ||
| 33032115 | 증권발행결과(자율공시) (유상증자(주주배정후 실권주 일반공모)) | 2025-11-11 | Korean | ||
| 33032112 | 증권발행실적보고서 | 2025-11-11 | Korean | ||
| 33031650 | 유상증자또는주식관련사채등의청약결과(자율공시) (주주배정후 실권주 일반공모) | 2025-11-10 | Korean | ||
| 33030451 | 유상증자또는주식관련사채등의청약결과(자율공시) (주주배정후 실권주 일반공모) | 2025-11-05 | Korean | ||
| 33028654 | 유상증자최종발행가액확정 (주주배정후 실권주 일반공모) | 2025-10-30 | Korean | ||
| 33028651 | [기재정정]투자설명서 | 2025-10-30 | Korean | ||
| 33028647 | [기재정정]주요사항보고서(유상증자결정) | 2025-10-30 | Korean | ||
| 33028614 | [발행조건확정]증권신고서(지분증권) | 2025-10-30 | Korean | ||
| 33027115 | 주식등의대량보유상황보고서(일반) | 2025-10-27 | Korean | ||
| 33026909 | 임원ㆍ주요주주특정증권등거래계획보고서 | 2025-10-24 | Korean | ||
| 33025950 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2025-10-22 | Korean | ||
| 33025948 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2025-10-22 | Korean | ||
| 33025604 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2025-10-21 | Korean | ||
| 33025601 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2025-10-21 | Korean | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
CORESTEMCHEMON Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17163/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17163 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17163 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17163 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17163}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CORESTEMCHEMON Inc. (id: 17163)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.